 Shares of IsoPlexis, a company creating tools to zoom in on the flurry of protein activity surrounding a single cell, began trading on Friday. The company aims to raise about 125 million with the IPO, which will be used to build the commercial team and advance the companys plans to play a bigger part in ... 